Clobetasol Attenuates White Matter Injury by Promoting Oligodendrocyte Precursor Cell Differentiation
Pediatric Neurosurgery · 2020 · 55 (4) · 188-196
DOI: 10.1159/000509521 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Neurosurgery, online erschienen am 09.10.2020. Verfasst von Xuewen Su und 9 weiteren Autor:innen. Beteiligte Einrichtung: Inner Mongolia People's Hospital, Hohhot, China. Hauptthemen laut MEDLINE: Brain Injuries, Oligodendrocyte Precursor Cells, White Matter. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 28 Literaturangaben.
Abstract (Originalsprache)
Introduction
White matter injury (WMI) is the most common brain injury in preterm infants and can result in life-long neurological deficits. The main cause of WMI is damage to the oligodendrocyte precursor cells (OPC) in the brain that results in delayed myelin sheath formation, or the destruction of existing myelin sheaths. OPC undergo highly regulated and strictly timed developmental changes that result in their transformation to mature oligodendrocytes capable of myelin production.
Objective
Studies have shown that clobetasol strongly promotes differentiation of OPC into myelin sheaths. Therefore, we hypothesized that clobetasol may be a therapeutic option for the treatment of preterm WMI.
Methods
We induced a WMI rat model and observed white matter damage under an optical microscope. Rats subjected to WMI were injected intraperitoneally with clobetasol (2 or 5 mg/kg daily) from day 1 to day 5 in the early treatment groups, or from day 6 to day 10 in the late treatment groups. After 17 days, the rats were sacrificed and the expression of myelin basic protein (MBP) was visualized using immunofluorescence. In addition, we evaluated myelin sheath formation using electron microscopy. The rats were also subjected to the suspension test, ramp test, and open field test to evaluate neurobehavioral functions.
Results
A rat model of WMI was successfully induced. It was found that clobetasol significantly induced MBP expression and myelin sheath formation and improved neurobehavioral function in the rats subjected to WMI.
Conclusions
Our results indicate that clobetasol attenuates WMI by promoting OPC differentiation, and it may be an effective therapeutic agent for the treatment of preterm WMI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Inner Mongolia People's Hospital, Hohhot, China.
- Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China.
- Inner Mongolia People's Hospital, Hohhot, China, SXW3605@163.com.
Zitieren
APA
Su, X., Yuan, H., Bai, Y., Chen, J., Sui, M., Zhang, X., Liang, Y., Feng, W., Dou, Z., & Zhu, H. (2020). Clobetasol Attenuates White Matter Injury by Promoting Oligodendrocyte Precursor Cell Differentiation. Pediatric Neurosurgery, 55(4), 188-196. https://doi.org/10.1159/000509521
Vancouver
Su X, Yuan H, Bai Y, Chen J, Sui M, Zhang X, et al. Clobetasol Attenuates White Matter Injury by Promoting Oligodendrocyte Precursor Cell Differentiation. Pediatric Neurosurgery. 2020;55(4):188-196. doi:10.1159/000509521
BibTeX
@article{Su2020,
author = {Su, Xuewen and Yuan, Haifeng and Bai, Yuxin and Chen, Junlong and Sui, Mingze and Zhang, Xiaomei and Liang, Yanyan and Feng, Wanyu and Dou, Zhongxia and Zhu, Hua},
title = {Clobetasol Attenuates White Matter Injury by Promoting Oligodendrocyte Precursor Cell Differentiation},
journal = {Pediatric Neurosurgery},
year = {2020},
volume = {55},
number = {4},
pages = {188--196},
doi = {10.1159/000509521}
}
EUVIMED